uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease

~ Alignment with FDA continues to support Accelerated Approval pathway ~

~ BLA submission planned for first quarter of 2026 ~

~ Conference call today at 8:30 a.m. ET ~

Read more at globenewswire.com